SSY Group (02005.HK): Azithromycin Dispersible Tablets (0.25g) Pass Generic Drug Quality and Efficacy Consistency Evaluation

Zhitong Finance APP news, SSY Group (02005.HK) announced that the group's Azithromycin Dispersible Tablets (0.25g) have obtained approval from China's National Medical Products Administration to pass the consistency evaluation of the quality and efficacy of generic drugs. Azithromycin is a macrolide antibacterial drug, mainly used to treat mild to moderate infections caused by susceptible strains of designated microorganisms.